Replies to post #164108 on Biotech Values

[DewDiligence]

ARIA/NVS—[Gleevec/Tasigna] provides likely 35%+ of their [NVS'] Operating Income.

Your 35% number is not even in the ballpark. Get a grip!

p.s. As long as you continue to make posts such as #msg-89986647, you won’t be taken seriously by readers of this board.